JUST IN: AstraZeneca’s Enhertu Gets EU’s Approval As Breast Cancer Treatment
JUST IN: AstraZeneca’s Enhertu Gets EU’s Approval As Breast Cancer Treatment—AstraZeneca and Daiichi Sankyo’s drug, Enhertu, has been approved by the European Union for treatment of adult patients with an aggressive form of breast cancer.
AstraZeneca said on Tuesday that Enhertu coud be used as a monotherapy in cases with unresectable or metastatic HER2-positive breast cancer.
The treatment was jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.
The European Medicines Agency (EMA) gave its endorsement late in June.
The EMA said Enhertu was effective at shrinking the tumour in patients with metastatic breast cancer or breast cancer that could not be removed by surgery
BREAKING: Kellyrae Wins BBNaija Season 9 No Loose Guard N100m Grand Prize [VIDEO]---Kellyrae, Big Brother…
Chelsea Vs Nottingham Forest live stream match has emerged The Genius Media Nigeria reports…
PHOTO: Yahoo Boy And His Girlfriend Burnt To Death After Refusing To Share Proceeds He…
CrossDresser Bobrisky Was Given Appropriate Cell – Nigerian Correctional Service---The Nigerian Correctional Service (NCoS) on…
BREAKING: Tinubu Finalises List Of New And Sacked Ministers----In a significant development, President Bola Tinubu…
FRESH: After Wife’s Death, Akwa Ibom Governor Umo Eno Appoints Daughter As First Lady---Governor Umo…